PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Eurofins Scientific SE (ERF.PA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINFR0014000MR3
SectorHealthcare
IndustryDiagnostics & Research

Highlights

Market Cap€10.93B
EPS€1.57
PE Ratio36.08
PEG Ratio1.32
Revenue (TTM)€6.51B
Gross Profit (TTM)€1.53B
EBITDA (TTM)€1.19B
Year Range€44.83 - €64.12
Target Price€59.80

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Eurofins Scientific SE

Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Eurofins Scientific SE, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5,000.00%10,000.00%15,000.00%20,000.00%25,000.00%30,000.00%35,000.00%December2024FebruaryMarchAprilMay
28,268.37%
358.87%
ERF.PA (Eurofins Scientific SE)
Benchmark (^GSPC)

S&P 500

Returns By Period

Eurofins Scientific SE had a return of -3.90% year-to-date (YTD) and -9.64% in the last 12 months. Over the past 10 years, Eurofins Scientific SE had an annualized return of 11.15%, while the S&P 500 benchmark had an annualized return of 10.64%, indicating that Eurofins Scientific SE performed slightly bigger than the benchmark.


PeriodReturnBenchmark
Year-To-Date-3.90%7.50%
1 month-6.25%-1.61%
6 months10.06%17.65%
1 year-9.64%26.26%
5 years (annualized)8.10%11.73%
10 years (annualized)11.15%10.64%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-4.88%-1.53%6.95%-2.51%
2023-10.60%11.56%10.53%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ERF.PA is 33, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of ERF.PA is 3333
Eurofins Scientific SE(ERF.PA)
The Sharpe Ratio Rank of ERF.PA is 3333Sharpe Ratio Rank
The Sortino Ratio Rank of ERF.PA is 2929Sortino Ratio Rank
The Omega Ratio Rank of ERF.PA is 2929Omega Ratio Rank
The Calmar Ratio Rank of ERF.PA is 4040Calmar Ratio Rank
The Martin Ratio Rank of ERF.PA is 3434Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Eurofins Scientific SE (ERF.PA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ERF.PA
Sharpe ratio
The chart of Sharpe ratio for ERF.PA, currently valued at -0.28, compared to the broader market-2.00-1.000.001.002.003.004.00-0.28
Sortino ratio
The chart of Sortino ratio for ERF.PA, currently valued at -0.22, compared to the broader market-4.00-2.000.002.004.006.00-0.22
Omega ratio
The chart of Omega ratio for ERF.PA, currently valued at 0.97, compared to the broader market0.501.001.500.97
Calmar ratio
The chart of Calmar ratio for ERF.PA, currently valued at -0.12, compared to the broader market0.002.004.006.00-0.12
Martin ratio
The chart of Martin ratio for ERF.PA, currently valued at -0.65, compared to the broader market-10.000.0010.0020.0030.00-0.65
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.17, compared to the broader market-2.00-1.000.001.002.003.004.002.17
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.11, compared to the broader market-4.00-2.000.002.004.006.003.11
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.501.001.501.38
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.65, compared to the broader market0.002.004.006.001.65
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.41, compared to the broader market-10.000.0010.0020.0030.008.41

Sharpe Ratio

The current Eurofins Scientific SE Sharpe ratio is -0.28. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Eurofins Scientific SE with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.28
2.58
ERF.PA (Eurofins Scientific SE)
Benchmark (^GSPC)

Dividends

Dividend History

Eurofins Scientific SE granted a 1.76% dividend yield in the last twelve months. The annual payout for that period amounted to €1.00 per share.


PeriodTTM20232022202120202019201820172016201520142013
Dividend€1.00€1.00€1.00€0.68€0.00€0.29€0.24€0.20€0.15€0.13€0.12€0.10

Dividend yield

1.76%1.70%1.49%0.62%0.00%0.58%0.74%0.39%0.36%0.41%0.57%0.51%

Monthly Dividends

The table displays the monthly dividend distributions for Eurofins Scientific SE. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024€0.00€0.00€0.00€0.00
2023€0.00€0.00€0.00€0.00€0.00€0.00€1.00€0.00€0.00€0.00€0.00€0.00
2022€0.00€0.00€0.00€0.00€0.00€0.00€1.00€0.00€0.00€0.00€0.00€0.00
2021€0.00€0.00€0.00€0.00€0.00€0.00€0.68€0.00€0.00€0.00€0.00€0.00
2020€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2019€0.00€0.00€0.00€0.00€0.00€0.00€0.29€0.00€0.00€0.00€0.00€0.00
2018€0.00€0.00€0.00€0.00€0.00€0.24€0.00€0.00€0.00€0.00€0.00€0.00
2017€0.00€0.00€0.00€0.00€0.00€0.20€0.00€0.00€0.00€0.00€0.00€0.00
2016€0.00€0.00€0.00€0.00€0.00€0.15€0.00€0.00€0.00€0.00€0.00€0.00
2015€0.00€0.00€0.00€0.00€0.00€0.13€0.00€0.00€0.00€0.00€0.00€0.00
2014€0.00€0.00€0.00€0.00€0.00€0.12€0.00€0.00€0.00€0.00€0.00€0.00
2013€0.10€0.00€0.00€0.00€0.00€0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%1.8%
Eurofins Scientific SE has a dividend yield of 1.76%, which is quite average when compared to the overall market.
Payout Ratio
20.0%40.0%60.0%80.0%100.0%120.0%63.7%
Eurofins Scientific SE has a payout ratio of 63.69%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2024FebruaryMarchAprilMay
-53.77%
-2.38%
ERF.PA (Eurofins Scientific SE)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Eurofins Scientific SE. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Eurofins Scientific SE was 86.35%, occurring on Oct 10, 2002. Recovery took 842 trading sessions.

The current Eurofins Scientific SE drawdown is 53.77%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-86.35%Nov 30, 2000472Oct 10, 2002842Jan 20, 20061314
-68.1%Nov 15, 2007330Mar 3, 2009793Mar 30, 20121123
-67.38%Jun 10, 1998222Apr 28, 1999160Dec 13, 1999382
-62.7%Sep 22, 2021540Oct 25, 2023
-45.75%Oct 31, 2017326Feb 11, 2019315May 8, 2020641

Volatility

Volatility Chart

The current Eurofins Scientific SE volatility is 12.06%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%December2024FebruaryMarchAprilMay
12.06%
3.64%
ERF.PA (Eurofins Scientific SE)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Eurofins Scientific SE over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items